For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) closed the day trading at $4.41 up 4.50% from the previous closing price of $4.22. In other words, the price has increased by $4.50 from its previous closing price. On the day, 1.22 million shares were traded. PHAT stock price reached its highest trading level at $4.475 during the session, while it also had its lowest trading level at $4.07.
Ratios:
For a better understanding of PHAT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.16 and its Current Ratio is at 4.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on February 14, 2025, initiated with a Overweight rating and assigned the stock a target price of $23.
On May 03, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $24.
Needham reiterated its Buy rating for the stock on January 05, 2024, while the target price for the stock was revised from $23 to $26.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 21 ’25 when Henderson Molly sold 6,583 shares for $6.59 per share. The transaction valued at 43,371 led to the insider holds 93,546 shares of the business.
Nabulsi Azmi sold 7,886 shares of PHAT for $51,957 on Jan 21 ’25. The Chief Operating Officer now owns 233,390 shares after completing the transaction at $6.59 per share. On Jan 21 ’25, another insider, Curran Terrie, who serves as the President and Chief Executive of the company, sold 19,109 shares for $6.59 each. As a result, the insider received 125,884 and left with 360,465 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 307099168 and an Enterprise Value of 564783936. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.56. Its current Enterprise Value per Revenue stands at 10.222 whereas that against EBITDA is -2.041.
Stock Price History:
The Beta on a monthly basis for PHAT is 0.56, which has changed by -0.4673913 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $4.18. The 50-Day Moving Average of the stock is -27.59%, while the 200-Day Moving Average is calculated to be -60.42%.
Shares Statistics:
Over the past 3-months, PHAT traded about 1.08M shares per day on average, while over the past 10 days, PHAT traded about 1470380 shares per day. A total of 68.52M shares are outstanding, with a floating share count of 38.64M. Insiders hold about 44.52% of the company’s shares, while institutions hold 60.31% stake in the company. Shares short for PHAT as of 1740700800 were 13923473 with a Short Ratio of 12.88, compared to 1738281600 on 14630807. Therefore, it implies a Short% of Shares Outstanding of 13923473 and a Short% of Float of 28.65.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
